ArticleClinical breast cancer2022

Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.

Tomi Akinyemiju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.